PAPER Palavicini JP, Wang H, Minond D, Bianchi E, Xu S, Lakshmana MK

RanBP9 overexpression down-regulates phospho-cofilin, causes early synaptic deficits and impaired learning, and accelerates accumulation of amyloid plaques in the mouse brain.

J Alzheimers Dis. 2014;39(4):727-40. PubMed: 24254706

PAPER Lee HR, Shin HK, Park SY, Kim HY, Lee WS, Rhim BY, Hong KW, Kim CD

Attenuation of β-amyloid-induced tauopathy via activation of CK2α/SIRT1: targeting for cilostazol.

J Neurosci Res. 2014 Feb;92(2):206-17. Epub 2013 Nov 19 PubMed: 24254769

PAPER Reynolds A

Alzheimer disease: focus on computed tomography.

Radiol Technol. 2013 Nov-Dec;85(2):187CT-211CT. PubMed: 24255154

PAPER Louis ED, Galecki M, Rao AK

Four Essential Tremor Cases with Moderately Impaired Gait: How Impaired can Gait be in this Disease?

Tremor Other Hyperkinet Mov (N Y). 2013;3 Epub 2013 Nov 4 PubMed: 24255798

PAPER Chiu M, Wesson V, Sadavoy J

Improving caregiving competence, stress coping, and mental well-being in informal dementia carers.

World J Psychiatry. 2013 Sep 22;3(3):65-73. PubMed: 24255878

T. Christopher Gamblin on ‘Godfather of Tau’ Skip Binder Dies at 63

COMMENT I was a postdoc in Skip’s lab at Northwestern from 1998-2002 and we were good friends and colleagues after that. Skip was incredibly generous with his time and friendship. He was always there for people, no matter what. His passing makes one realize just

T. Christopher Gamblin

University of Kansas
United States

Kenneth Kosik on ‘Godfather of Tau’ Skip Binder Dies at 63

COMMENT Irreverent, witty, lively, and always full of kindness and generosity, Skip’s untimely death must give pause to all of us who knew him, and many more who only knew of him. We should build upon his insights as we delve ever more deeply into the diseases th

PAPER Citrome L

A review of the pharmacology, efficacy and tolerability of recently approved and upcoming oral antipsychotics: an evidence-based medicine approach.

CNS Drugs. 2013 Nov;27(11):879-911. PubMed: 24062193

PAPER Giaccone G, Giaccone G, DiFede G, Giovagnoli AR, Tagliavini F

A novel missense mutation in Psen2 gene associated with a clinical phenotype of frontotemporal dementia

Alzheimers Dement. 2008;4(S2):T590

PAPER Gallo M, Tomaino C, Bernardi L, Maletta R, Anfossi M, Geracitano S, Vasso F, Puccio G, Colao R, Frangipane G, Mirabelli M, Smirne N, Muraca MG, De Vito O, Bruni AC

PS1 polymporphism and a novel PS2 mutation in a patient with late-onset familial Alzheimer's disease

Alzheimers Dement. 2008;4(S2):T585

PAPER Piscopo P, Talarico G, Spadoni O, Malvezzi-Campeggi L, Crestini A, Gasparini M, Vanacore N, Lenzi GL, Pocchiari M, Confaloni A, Bruno G

A novel Italian presenilin 2 mutation (S175Y)

Alzheimers Dement. 2008;4(S2):T595.

PAPER Sorbi S, Tedde A, Nacmias B, Ciantelli M, Caffarra P, Ghidoni E, Bracco L, Piccini C

Novel presenilin 1 and presenilin 2 mutations in early-onset Alzheimer's disease families

Neurobiol Aging. 2002 Jul-Aug;23(1S):312.

PAPER Clarimón J, Guerreiro R, Lleó A, Guardia C, Blesa F, Gómez-Isla T, Boada M, Bullido MJ, Ferrer I, Martínez-Lage P, Masdeu J, Molina L, Molinuevo JL, Pastor P, Pérez-Tur J, Rey MJ, Sánchez-Valle R, Tàrraga L, Valdivieso F, Singleton A, Hardy J

Genetic screening in a large cohort of early-onset Alzheimer's disease patients from Spain: novel mutations in the amyloid precursor protein and presenilines

Alzheimers Demen. 2008 Jul;4(4 Suppl):T583.

PAPER Hunt L

Memantine improves outlook, cuts healthcare costs in AD

PharmacoEconomics & Outcomes News. 422: 3-4, 2003 Jul 26